Cerebral venous sinus thrombosis (CVST) is a rare but serious condition characterized by blood clot formation in the dural venous sinuses. It can manifest with symptoms ranging ... This case report ...

Cerebral venous sinus thrombosis (CVST) following novel coronavirus-2019 (nCoV-19) vaccination is a rare adverse effect. We report the first case of CVST associated with ChAdOx1 vaccination, with ...

Cerebral venous sinus thrombosis (CVST) is Cerebral venous sinus thrombosis (CVST) is a rare and potentially deadly condition. Common etiologies include hypercoagulable diseases, low flow states ...

We herein report a case of a child with tuberculous meningitis and COVID-19 coinfection complicated by hydrocephalus, arterial ischaemic stroke and extensive cerebral sinus venous thrombosis. Both ...

Dural sinus malformations (DSMs ... transarterial embolization has shown promise in reducing the size of giant venous lakes and arteriovenous fistulas associated with DSMs. This approach appears ...

However, its use in patients with cerebral venous sinus thrombosis-related CVSS has been less reported. Purpose To explore the safety and efficacy of stenting for patients with cerebral venous sinus ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

They have proved to be effective but carry high rates of symptom recurrence or procedural complications. Focal dural venous sinus stenoses have been identified in many patients with IIH, leading to ...

Cerebral venous thrombosis (CVT) is a rare but serious condition where blood clots form in the brain's venous sinuses, leading to increased intracranial pressure and potential neurological damage.

Dr SFTM de Bruijn, Department Of Neurology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands sdebruijn@ neurologie-denhaag.n The prognosis of cerebral venous sinus thrombosis (CVST) ...

Patients who received the original 2-dose monovalent mRNA COVID-19 vaccine series were less likely than unvaccinated individuals to be hospitalized for COVID-19-associated venous thromboembolism.